THX PHARMA SACA (ALTHX.PA) Stock Income Statement
Europe - Euronext Paris - EPA:ALTHX - FR0013286259 - Common Stock
2 EUR
+0.06 (+3.09%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | 1.01M | 883.90K | |||
| Gross Profit | N/A | N/A | N/A | -1.01M | -883.90K | |||
| Operating Expenses | 3.55M | 2.63M | 7.64M | 5.25M | 8.63M | |||
| Research and Development | N/A | N/A | 3.80M | 2.77M | 4.58M | |||
| Selling, General, and Administrative Expenses | 1.96M | 2.16M | 2.74M | 3.36M | 2.81M | |||
| Operating Income | -3.55M | -2.63M | -7.64M | -6.26M | -9.51M | |||
| Interest Income/Expense | N/A | N/A | -7.20K | -587.80K | -396.60K | |||
| Other Income/Expense | 60.00K | 50.00K | 21.10K | 429.20K | 0.00 | |||
| Non Recurring Items | 140.00K | 100.00K | 0.00 | -771.20K | -770.00K | |||
| Income Before Taxes | -3.45M | -2.53M | -7.63M | -7.19M | -9.91M | |||
| Income Tax | -520.00K | -770.00K | -801.80K | -620.00K | -1.76M | |||
| Net Income | -2.94M | -1.77M | -6.83M | -6.57M | -8.15M | |||
| EBITDA | -3.45M | -2.53M | -7.39M | -5.93M | -8.35M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.36 | -0.22 | -0.85 | -1.18 | -1.56 | |||
| Statistics | ||||||||
All data in EUR